Search

everythinglearnresearchcommunity

for

Search:↓

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Low IGF-1 and high HDL cholesterol levels are linked to more hair loss in middle-aged women.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

People with blood group O may have a higher risk of developing post-COVID-19 syndrome.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Androgenetic alopecia is more common in Indian men than women, and family history is a strong risk factor.

Certain hairstyles and less hair oil use in African American girls can lead to scalp conditions like traction alopecia and seborrheic dermatitis.

Overweight smokers have worse hair loss.

Different prostate cancer treatments have similar risks of secondary cancers and related mortality when considering patient age and smoking history.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

Many survivors of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Togo suffer long-term eye and skin problems.

People with androgenetic alopecia have different lipid levels in their blood, which vary between men and women, and may be linked to a higher risk of metabolic syndrome.

People with hair loss have low zinc levels; zinc supplements and laser therapy may help.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

Low iron and vitamin D levels are linked to hair loss in women.

Skin diseases significantly lower the quality of life for patients in southern Brazil, especially for younger, single, and lower-income individuals.

People with lichen planus are more likely to have dyslipidemia, especially higher triglyceride levels.

Early hair loss may indicate prostate issues.

Finasteride does not prevent bladder cancer.

Mohs micrographic surgery is effective for early-stage non-melanoma skin cancers on the lips, with basal cell carcinoma more common on the upper cutaneous lip and squamous cell carcinoma more common on the lower vermilion lip.

Hair loss linked to kidney stones in people under 60.

Women with telogen effluvium have lower levels of iron, folate, and vitamin B12.

Some medications and supplements can cause serious side effects, including hair loss, heart rhythm problems, liver injury, and other health issues.

Hair loss linked to prostate enlargement; stress and family history important factors.

People with certain skin disorders are more likely to have alcohol problems, especially if they also have mental health issues like depression and anxiety.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Some early breast cancer patients have long-term hair loss after chemotherapy, especially older and postmenopausal women.

Patients treated in Respiratory Intensive Care Units for COVID-19 are more likely to get mood disorders than those in other care settings.

New method finds genetic links between Type 2 Diabetes and Prostate Cancer not seen before.